Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

Mint flavor in vaping liquids associated with worse lung function in e-cigarette users

Adding mint flavor to e-cigarette liquids produces more vapor particles and is associated with worse lung function in those who smoke, report researchers from the University of Pittsburgh in Respiratory Research today.

11 Apr 2023

Regulatory T cell populations descend from two different origins, finds study

A regulatory class of human T cells descends from two different origins, one that relates to autoimmunity and one that relates to protective immunity, according to a new study led by Children's Hospital of Philadelphia (CHOP).

7 Apr 2023

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with men (MSM) and transgender women who took the medication within 72 hours of having condomless sex, according to findings published today in the New England Journal of Medicine.

6 Apr 2023

Children with asthma more likely to develop anxiety

Children diagnosed with asthma were at significantly increased risk of developing anxiety, a University of Queensland study has found.

5 Apr 2023

Mosquitoes' saliva contains immune-dampening substances to increase infectivity of dengue viruses

The saliva of mosquitoes infected with dengue viruses contains a substance that thwarts the human immune system and makes it easier for people to become infected with these potentially deadly viruses, new research reveals.

4 Apr 2023

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis.

4 Apr 2023

UCSD engineers develop a biodegradable polymer system to treat rheumatoid arthritis

A team led by engineers at the University of California San Diego has developed a biodegradable polymer system to treat rheumatoid arthritis, an autoimmune and inflammatory disease, by working in concert with the power of the human immune system.

4 Apr 2023

N-abling the acceleration of the life sciences through precision dispensing

In this interview, we speak to Holger Eickhoff, CEO and Founder of Scienion, about their latest technology, The Nucleus Automation Ecosystem.

From SCIENION GmbH 4 Apr 2023

Developing lipid nanoparticles to carry mRNA specifically to the pancreas

Therapeutics that use mRNA-;like some of the COVID-19 vaccines-;have enormous potential for the prevention and treatment of many diseases.

31 Mar 2023

What is the effect of supplementing raisins on improving cognitive performance, cardiovascular risk factors, and markers of inflammation?

Researchers devised a protocol to examine the effect of raisin supplementation on cognitive function in older adults.

31 Mar 2023

AI tool helps clinicians to identify and treat lung cancer at their early stages

A new artificial intelligence (AI) tool is helping physicians at Atrium Health Wake Forest Baptist better predict and diagnose lung cancer in patients.

29 Mar 2023

Children exposed to pet cats or dogs during infancy may have fewer food allergies

In an analysis of over 65,000 infants from Japan, children exposed to pet cats or indoor dogs during fetal development or early infancy tended to have fewer food allergies compared to other children, according to a study published March 29, 2023 in the open-access journal PLOS ONE by Hisao Okabe from the Fukushima Regional Center for the Japan Environment and Children's Study, Japan, and colleagues.

29 Mar 2023

Children with in utero exposure to maternal COVID-19 infection more likely to develop obesity

Children born to mothers who had COVID-19 during pregnancy may be more likely to develop obesity, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

29 Mar 2023

Scientists identify a distinct role of retinoic acid during immune response of the gut

A team of scientists from the Renaissance School of Medicine at Stony Brook University have identified a distinct role of retinoic acid, a metabolite of vitamin A, during the immune response of the gut.

28 Mar 2023

NIH scientists discover an autoinflammatory disease caused by mutations in the LYN gene

Scientists have identified an autoinflammatory disease caused by mutations in the LYN gene, an important regulator of immune responses in health and disease.

28 Mar 2023

The connection between gut microbiota, the gut–brain axis, and brain aging: can polyphenols have an impact?

A review published in the Antioxidants journal aimed to understand the impact of gut microbiota on brain aging.

28 Mar 2023

Myeloid cells can harbor HIV in people taking antiretroviral therapy

A subset of white blood cells, known as myeloid cells, can harbor HIV in people who have been virally suppressed for years on antiretroviral therapy, according to findings from a small study supported by the National Institutes of Health.

27 Mar 2023

Tulane receives up to $16 million to move nasal pneumonia vaccine from the lab to clinical trials

The National Institute of Allergy and Infectious Diseases awarded an up to $16 million contract to Tulane University to bring to phase one clinical trial a nasal spray vaccine university researchers invented to thwart antibiotic-resistant Klebsiella pneumoniae, a leading cause of pneumonia.

24 Mar 2023

TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis

For over a century, El Paso has long been a sanctuary for individuals suffering from tuberculosis. It will soon be home to groundbreaking research that prevents the debilitating disease.

24 Mar 2023

Antibodies produced by newly developed mRNA vaccines are transferred from pregnant rabbits to offspring

Newly developed mRNA vaccines against Zika virus and HIV-1 produced strong antibody responses that transferred from pregnant rabbits to their offspring, researchers report March 24th in the journal Molecular Therapy.

24 Mar 2023

Allergy News and Research

Further Reading

Mint flavor in vaping liquids associated with worse lung function in e-cigarette users

Regulatory T cell populations descend from two different origins, finds study

Post-exposure doxycycline approach leads to two-thirds reduction in STI incidence

Children with asthma more likely to develop anxiety

Mosquitoes' saliva contains immune-dampening substances to increase infectivity of dengue viruses

Novel immunotherapy-based approach for low-grade lymphomatoid granulomatosis improves patient survival

UCSD engineers develop a biodegradable polymer system to treat rheumatoid arthritis

N-abling the acceleration of the life sciences through precision dispensing

Developing lipid nanoparticles to carry mRNA specifically to the pancreas

What is the effect of supplementing raisins on improving cognitive performance, cardiovascular risk factors, and markers of inflammation?

AI tool helps clinicians to identify and treat lung cancer at their early stages

Children exposed to pet cats or dogs during infancy may have fewer food allergies

Children with in utero exposure to maternal COVID-19 infection more likely to develop obesity

Scientists identify a distinct role of retinoic acid during immune response of the gut

NIH scientists discover an autoinflammatory disease caused by mutations in the LYN gene

The connection between gut microbiota, the gut–brain axis, and brain aging: can polyphenols have an impact?

Myeloid cells can harbor HIV in people taking antiretroviral therapy

Tulane receives up to $16 million to move nasal pneumonia vaccine from the lab to clinical trials

TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis

Antibodies produced by newly developed mRNA vaccines are transferred from pregnant rabbits to offspring

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News